YALE-MAYO FDA CENTER FOR EXCELLENCE IN REGULATORY SCIENCE AND INNOVATION
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Yale-Mayo collaborative center developing regulatory science expertise and innovation to improve FDA drug and device approval processes.
Strengthens FDA's scientific capacity to evaluate novel therapeutics faster, supporting U.S. competitiveness in pharmaceutical and medical device innovation.
Signals investment in regulatory infrastructure that accelerates time-to-market for biotech companies, benefiting downstream pharmaceutical and device manufacturers.
Enhances U.S. regulatory efficiency to compete with China's faster approval pathways while maintaining safety standards for innovative therapies.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002175.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_U01FD005938_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.